Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 9, 2026, 10:45 AM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 9, 2026, 10:45 AM EDT
Over the latest trailing 12-month period, total return cagr is +54.52%. The comparable SPY value is +19.37%. Year-to-date total return is +32.13%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in JNJ
$228,487
(22.8x return)
Invested on Sep 3, 1996
Growth of $10,000 in SPY (S&P 500)
$192,542
(19.3x return)
Invested on Sep 3, 1996
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
YTD Total Return
+32.1%
1-Year Total Return
+54.5%
Current Dividend Yield
1.96%
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | +51.1% | +54.5% | +3.4% |
| 3 Years | +18.8% | +22.2% | +3.4% |
| 5 Years | +9.4% | +12.5% | +3.1% |
| 10 Years | +8.5% | +11.4% | +3.0% |
| 15 Years | +9.9% | +13.1% | +3.2% |
| 20 Years |
| +7.5% |
| +10.6% |
| +3.2% |